WHO ICTRP trial
NOT APPLICABLE
EUCTR2010-024467-40-ES · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-024467-40-ES |
|---|---|
| Public title | NOT APPLICABLE |
| Scientific title | OFATUMUMAB COMO PARTE DEL RÉGIMEN DE ACONDICIONAMIENTO DE INTENSIDAD REDUCIDA PARA PACIENTES CON LEUCEMIA lINFÁTICA CRÓNICA DE ALTO RIESGO QUE RECIBEN UN TRASPLANTE ALOGÉNICO DE PROGENITORES HEMATOPOYÉTICOS: UN ESTUDIO PILOTO CONJUNTO DEL GRUPO ESPAÑOL DE TRASPLANTE HEMATOPOYÉTICO Y TERAPIA CELULAR… |
| Primary sponsor | GRUPO ESPAÑOL DE TRASPLANTE HEMATOPOYÉTICO Y TERAPIA CELULAR (GETH) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Spain |
| Conditions | PACIENTES CON LEUCEMIA LINFATICA CRONICA DE ALTO RIESGO CONINDICACION DE TRASPLANTE ALOGÉNICO DE INTENSIDAD REDUCIDA Y DISPONIBILIDAD DE DONANTE, YA SEA FAMILIAR O NO EMPARENTADO;Therapeutic area: Diseases [C] - Blood and lymphatic diseases… |
| Interventions | Product Name: OFATUMUMAB Product Code: GSK1841157 Pharmaceutical Form: Solution for injection INN or Proposed INN: OFATUMUMAB CAS Number: 679818-59-8 Current Sponsor code: GSK1841157 Concentration unit: mg/ml milligram(s)/millilitre… |
| Registration date | Dec 7, 2011 |
| Target size | 25 |
| Secondary IDs | GETH-CLL4 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: